Table 5.
Study ID | Patient Demographic (Gender, Age) | Route of Administration | Cause of Death | Fentanyl Concentration (µg/mL) from Specified Blood Source | Evidence of Concomitant Drugs |
---|---|---|---|---|---|
Nara et al,34 2019 | Female, 40–49 | Transdermal | Fentanyl Overdose | Femoral: 0.051 Cardiac: 0.033 |
Yes |
Jumbelic et al,27 2010 | Female 43 | Transdermal | Fentanyl Overdose | Subclavian: 0.022 | Yes |
Jumbelic et al,27 2010 | Male 49 | Transdermal | Fentanyl Overdose | Femoral: 0.022 | Yes |
Jumbelic et al,27 2010 | Male 28 | Transdermal | Fentanyl Overdose | Subclavian: 0.028 | Yes |
Jumbelic et al,27 2010 | Male 16 | Transdermal | Fentanyl Overdose | Iliac: 0.005 | Yes |
Jumbelic et al,27 2010 | Female 49 | Transdermal | Fentanyl Overdose | Subclavian: 0.01 | Yes |
Jumbelic et al,27 2010 | Male 37 | Transdermal | Fentanyl Overdose | Femoral: 0.013 | Yes |
Jumbelic et al,27 2010 | Male 18 | Transdermal | Fentanyl Overdose | Cardiac: 0.014 | Yes |
Jumbelic et al,27 2010 | Female 43 | Transdermal | Fentanyl Overdose | Iliac: 0.019 | Yes |
Edinboro et al,23 1997 | Female 83 | Transdermal | Fentanyl Overdose | Source not specified: 0.025 | No |
Tharp et al,35 2004 | Male 35 | Intravenous | Fentanyl Overdose | Source not specified: 0.005–0.027 | No |
Tharp et al,35 2004 | Male 38 | Intravenous | Fentanyl Overdose | Source not specified: 0.005–0.027 | No |
Tharp et al,35 2004 | Male 42 | Intravenous | Fentanyl Overdose | Source not specified: 0.005–0.027 | Yes |
Tharp et al,35 2004 | Male 39 | Intravenous | Fentanyl Overdose | Source not specified: 0.005–0.027 | Yes |
Lilleng et al,31 2004 | Male 41–42 | Intravenous | Mixed Drug Toxicity | Source not specified: 0.0027 | Yes |
Lilleng et al,31 2004 | Male 41–42 | Intravenous | Fentanyl Overdose | Source not specified: 0.0138 | Yes |
Kronstrand et al,29 1997 | Male 29 | Intravenous | Fentanyl Overdose | Femoral: 0.004 | Yes |
Kronstrand et al,29 1997 | Male 22 | Intravenous | Fentanyl Overdose | Femoral: 0.005 | Yes |
Kronstrand et al,29 1997 | Male 40 | Intravenous | Fentanyl Overdose | Femoral: 0.017 | Yes |
Kronstrand et al,29 1997 | Male 44 | Intravenous | Fentanyl Overdose | Femoral: 0.005 | Yes |
Kronstrand et al,29 1997 | Male 42 | Intravenous | Fentanyl Overdose | Femoral: 0.006 | Yes |
Kronstrand et al,29 1997 | Male 42 | Intravenous | Fentanyl Overdose | Femoral: 0.009 | Yes |
Kronstrand et al,29 1997 | Male 26 | Intravenous | Fentanyl Overdose | Femoral: 0.002 | Yes |
Woodall et al,36 2008 | Male 42 | Transdermal | Fentanyl Overdose | Cardiac: 0.022 | Yes |
Woodall et al,36 2008 | Female 20 | Transdermal | Fentanyl Overdose | Femoral: 0.013 | Yes |
Woodall et al,36 2008 | Female 51 | Transdermal | Mixed Drug Toxicity | Femoral: 0.097 | Yes |
Woodall et al,36 2008 | Female 42 | Transdermal | Fentanyl + Ethanol Toxicity | Femoral: 0.028 Cardiac: 0.032 |
Yes |
Woodall et al,36 2008 | Male 32 | Transdermal | Fentanyl + Ethanol Toxicity | Cardiac 0.007 | Yes |
Woodall et al,36 2008 | Male 41 | Transdermal | Fentanyl + Ethanol Toxicity | Cardiac: 0.008 | Yes |
Carson et al,21 2010 | Male 28 | Transmucosal | Mixed Drug Toxicity (Preceding Aspiration) | Femoral: 0.0086 | Yes |